acitretin has been researched along with Vulvar Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
El-Ghobashy, A; Elghobashy, M; Fox, E; Hamad, H; Moiemen, N | 1 |
Murphy, D; Redman, C; Thomas, E | 2 |
Mehta, RK; Rytina, E; Sterling, JC | 1 |
2 review(s) available for acitretin and Vulvar Neoplasms
Article | Year |
---|---|
Premalignant vulval disorders.
Topics: Acitretin; Carcinoma in Situ; Clobetasol; Female; Humans; Lichen Sclerosus et Atrophicus; Precancerous Conditions; Randomized Controlled Trials as Topic; Treatment Outcome; Vulva; Vulvar Neoplasms | 2002 |
Premalignant vulval disorders.
Topics: Acitretin; Carcinoma in Situ; Clobetasol; Female; Humans; Lichen Sclerosus et Atrophicus; Precancerous Conditions; Vulva; Vulvar Neoplasms | 2002 |
2 other study(ies) available for acitretin and Vulvar Neoplasms
Article | Year |
---|---|
Oral retinoid, acitretin, is effective in the management of resistant recurrent vulval verrucous carcinoma: A case report.
Topics: Acitretin; Carcinoma, Squamous Cell; Carcinoma, Verrucous; Female; Humans; Neoplasm Recurrence, Local; Vulvar Neoplasms | 2020 |
Treatment of verrucous carcinoma of vulva with acitretin.
Topics: Acitretin; Carcinoma, Verrucous; Female; Follow-Up Studies; Humans; Keratolytic Agents; Middle Aged; Neoplasm Recurrence, Local; Vulvar Neoplasms | 2000 |